Clinical trial
Exploratory Study on Gene Profiling of Circulating Tumor DNA(ctDNA) of Multiple Primary Cancers (MPC) and Its Value in Guidance of Clinical Choice of Drugs
NCT05164510 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study on Gene Profiling of Circulating Tumor DNA(ctDNA) of Multiple Primary Cancers (MPC) and Its Value in Guidance of Clinical Choice of Drugs
- Lead sponsor
- Fudan University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 31, 2021
- Completion date
- September 30, 2023
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple primary cancers